BioMarin Pharmaceutical Inc
BMRN61.150USD
+9.200+17.71%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
11.75BMarket Cap
22.49P/E TTM
BioMarin Pharmaceutical Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
2.85B
17.97%
EPS(YoY)
2.25
151.68%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its total revenue reached 2.85B, with a year-on-year change of 17.97%.
What is the Earnings Per Share (EPS) of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 2.246, with a year-on-year change of 151.68%.
What is the net income of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its net income was 426.86M, with a year-on-year change of 154.62%.
What is the net margin of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its net profit margin was 14.96%, with a year-on-year change of 115.84%.
What is the gross margin of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its gross margin was 78.15%, with a year-on-year change of 3.60%.
What is the debt-to-asset ratio of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its debt-to-asset ratio was 8.53%, with a year-on-year change of -46.31%.
What is the Return on Equity (ROE) of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its Return on Equity (ROE) was 8.05%, with a year-on-year change of 129.31%.
What is the Return on Assets (ROA) of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its Return on Assets (ROA) was 6.17%, with a year-on-year change of 143.32%.
What is the operating profit of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its operating profit was 570.04M, with a year-on-year change of 206.85%.
What are the current assets of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its current assets were 3.23B, with a year-on-year change of 9.35%.
What are the total assets of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its total assets of BioMarin Pharmaceutical Inc were 6.99B, with a year-on-year change of 2.15%.
What are the total liabilities of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its total liabilities of BioMarin Pharmaceutical Inc were 1.33B, with a year-on-year change of -29.58%.
What is the total equity of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its total equity of BioMarin Pharmaceutical Inc was 5.66B, with a year-on-year change of 14.27%.
What is the net operating income of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its net operating income of BioMarin Pharmaceutical Inc was 426.86M, with a year-on-year change of 154.62%.
What is the net investment of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its net investment of BioMarin Pharmaceutical Inc was 136.49M, with a year-on-year change of 222.70%.
What is the net financing of BioMarin Pharmaceutical Inc?
According to BioMarin Pharmaceutical Inc's FY2024 earnings report, its net financing of BioMarin Pharmaceutical Inc was -526.45M, with a year-on-year change of -2711.17%.
